Overview

Caring Brands, Inc. released its Form 10-K annual report for the year ended December 31, 2025. The company, based in Jupiter, Florida, is a wellness consumer products business focused on over-the-counter (OTC) and cosmetic products. It operates with a robust product pipeline and is listed on NASDAQ under the trading symbol “CABR”.

Key Points from the Annual Report

1. Business Model and Product Pipeline

• Caring Brands offers a diverse range of OTC and cosmetic products targeting hair loss, eczema, psoriasis, vitiligo, jellyfish sting protection, and women’s sexual wellness.
• The company asserts that all products have an established mechanism of action, efficacy proven through controlled clinical trials, are protected by patents, and possess commercial stability.
• Intellectual property is a cornerstone, with a portfolio of both issued and published patents across multiple jurisdictions, including the U.S. and China.
• As of June 30, 2025, the company had 13,336,925 shares of common stock outstanding, with authorization for up to 100 million shares (par value \$0.001).

2. Financial and Corporate Highlights

• The aggregate market value of common stock held by non-affiliates as of June 30, 2025, was approximately \$3.96 million.
• As of March 30, 2026, the company had 12,341,506 shares outstanding.
• The company is classified as a “smaller reporting company,” a “non-accelerated filer,” and an “emerging growth company.” This means reduced compliance and disclosure burdens, which may influence regulatory costs and investor perceptions.
• No documents are incorporated by reference in this report, suggesting all relevant disclosures are contained within the filing itself.
• There is no indication of corrections or restatements to previously issued financial statements, and the company is not a shell company.

3. E-Commerce and Growth Strategy

• The company is heavily focused on direct-to-consumer sales via its e-commerce platform, CaringBrands.com. This site will be the central hub for investor information, press releases, clinical trial updates, lab reports, and brand information.
• There are ongoing discussions to expand onto third-party e-commerce platforms, but no formal agreements have been signed. The immediate strategy is to grow the online presence before pursuing traditional retail channels.
• The company plans to pursue acquisition opportunities in the branded consumer products sector, particularly OTC and skincare brands that do not require additional FDA approval. No definitive acquisition agreements are in place as of the report date.

4. Competitive Landscape and Risk Factors

• Caring Brands acknowledges intense competition from major pharmaceutical and biotechnology firms, as well as public and private research institutions. These competitors may have greater resources and faster response capabilities.
• The company’s ability to maintain a competitive advantage depends on rapid innovation, brand trust, and effective consumer education.
• Risks include rapidly changing global, national, and regional economic conditions, and the evolving landscape of cannabis-related medical research.

5. Regulatory Environment

• The company’s products are subject to U.S. Food and Drug Administration (FDA) regulations, as well as other domestic and international OTC and cosmetic product requirements.
• The regulatory status of various product categories and the outcome of future regulatory changes could have a material impact on the business.

Shareholder-Relevant and Price-Sensitive Information

• Growth Potential: The company is actively pursuing acquisitions and expansion, which could materially impact future revenues and market positioning.
• E-Commerce Focus: A strong emphasis on direct-to-consumer sales and digital marketing may lead to higher margins and growth, but also exposes the company to changing online retail trends.
• Patent Portfolio: The existence of issued and published patents provides a defensible moat for its product pipeline, but details on patent expiry and scope should be closely monitored by investors.
• No Retail Agreements Yet: The lack of formal retail distribution agreements may limit near-term revenue growth, but also means potential upside if/when such deals are secured.
• Emerging Growth Company Status: The company’s regulatory status allows for certain exemptions from reporting requirements, which can affect transparency and investor risk assessments.
• Market Value and Share Count: With a market float of just under \$4 million and a relatively low number of shares outstanding, the stock could be subject to higher volatility.

Forward-Looking Statements and Disclaimers

The report contains extensive forward-looking statements regarding the company’s goals, strategies, product development plans, financial condition, and acquisition intentions. Management cautions that actual results may differ significantly due to known and unknown risks, competitive pressures, market changes, and regulatory developments. Investors should not place undue reliance on these forward-looking statements and should consider the risk factors outlined in the annual report.

Disclaimer: This article is a summary and interpretation of Caring Brands, Inc.’s 2025 Form 10-K annual report and is provided for informational purposes only. It does not constitute investment advice or a recommendation to buy, sell, or hold any securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. The company’s actual results and financial condition may differ materially from those expressed or implied in this summary.

View Caring Brands, Inc. Historical chart here